Lumykras Европска Унија - Исландски - EMA (European Medicines Agency)

lumykras

amgen europe bv - sotorasib - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Amoxin Mixtúruduft, dreifa 100 mg/ml Исланд - Исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

amoxin mixtúruduft, dreifa 100 mg/ml

ratiopharm gmbh* - amoxicillinum tríhýdrat - mixtúruduft, dreifa - 100 mg/ml